204 related articles for article (PubMed ID: 22672920)
1. An exploratory study to clarify the cluster of symptoms predictive of chemotherapy-related nausea using random forest modeling.
Molassiotis A; Farrell C; Bourne K; Brearley SG; Pilling M
J Pain Symptom Manage; 2012 Nov; 44(5):692-703. PubMed ID: 22672920
[TBL] [Abstract][Full Text] [Related]
2. The impact of chemotherapy-related nausea on patients' nutritional status, psychological distress and quality of life.
Farrell C; Brearley SG; Pilling M; Molassiotis A
Support Care Cancer; 2013 Jan; 21(1):59-66. PubMed ID: 22610269
[TBL] [Abstract][Full Text] [Related]
3. Nausea still the poor relation in antiemetic therapy? The impact on cancer patients' quality of life and psychological adjustment of nausea, vomiting and appetite loss, individually and concurrently as part of a symptom cluster.
Pirri C; Bayliss E; Trotter J; Olver IN; Katris P; Drummond P; Bennett R
Support Care Cancer; 2013 Mar; 21(3):735-48. PubMed ID: 22976921
[TBL] [Abstract][Full Text] [Related]
4. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
5. Understanding the concept of chemotherapy-related nausea: the patient experience.
Molassiotis A; Stricker CT; Eaby B; Velders L; Coventry PA
Eur J Cancer Care (Engl); 2008 Sep; 17(5):444-53. PubMed ID: 18637116
[TBL] [Abstract][Full Text] [Related]
6. Relieving nausea and vomiting in patients with cancer: a treatment algorithm.
Johnson MH; Moroney CE; Gay CF
Oncol Nurs Forum; 1997; 24(1):51-7. PubMed ID: 9007907
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy-induced nausea and vomiting in breast cancer patients: a prospective observational study.
Booth CM; Clemons M; Dranitsaris G; Joy A; Young S; Callaghan W; Trudeau M; Petrella T
J Support Oncol; 2007 Sep; 5(8):374-80. PubMed ID: 17944146
[TBL] [Abstract][Full Text] [Related]
8. The efficacy and cost effectiveness of new antiemetic guidelines.
Engstrom C; Hernandez I; Haywood J; Lilenbaum R
Oncol Nurs Forum; 1999 Oct; 26(9):1453-8. PubMed ID: 11064877
[TBL] [Abstract][Full Text] [Related]
9. Symptom clusters in children and adolescents receiving cisplatin, doxorubicin, or ifosfamide.
Hockenberry MJ; Hooke MC; Gregurich M; McCarthy K; Sambuco G; Krull K
Oncol Nurs Forum; 2010 Jan; 37(1):E16-27. PubMed ID: 20044328
[TBL] [Abstract][Full Text] [Related]
10. Impact of chemotherapy-associated nausea and vomiting on patients' functional status and on costs: survey of five Canadian centres.
O'Brien BJ; Rusthoven J; Rocchi A; Latreille J; Fine S; Vandenberg T; Laberge F
CMAJ; 1993 Aug; 149(3):296-302. PubMed ID: 8339175
[TBL] [Abstract][Full Text] [Related]
11. Effect of concord grape juice on chemotherapy-induced nausea and vomiting: results of a pilot study.
Ingersoll GL; Wasilewski A; Haller M; Pandya K; Bennett J; He H; Hoffmire C; Berry C
Oncol Nurs Forum; 2010 Mar; 37(2):213-21. PubMed ID: 20189927
[TBL] [Abstract][Full Text] [Related]
12. The oral NK(1) antagonist, aprepitant, given with standard antiemetics provides protection against nausea and vomiting over multiple cycles of cisplatin-based chemotherapy: a combined analysis of two randomised, placebo-controlled phase III clinical trials.
de Wit R; Herrstedt J; Rapoport B; Carides AD; Guoguang-Ma J; Elmer M; Schmidt C; Evans JK; Horgan KJ
Eur J Cancer; 2004 Feb; 40(3):403-10. PubMed ID: 14746859
[TBL] [Abstract][Full Text] [Related]
13. Symptom cluster patterns during the first year after diagnosis with cancer.
Molassiotis A; Wengström Y; Kearney N
J Pain Symptom Manage; 2010 May; 39(5):847-58. PubMed ID: 20226621
[TBL] [Abstract][Full Text] [Related]
14. Clinical predictors of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adjuvant doxorubicin and cyclophosphamide.
Shih V; Wan HS; Chan A
Ann Pharmacother; 2009 Mar; 43(3):444-52. PubMed ID: 19193584
[TBL] [Abstract][Full Text] [Related]
15. Anticipatory nausea among ambulatory cancer patients undergoing chemotherapy: prevalence, associated factors, and impact on quality of life.
Akechi T; Okuyama T; Endo C; Sagawa R; Uchida M; Nakaguchi T; Sakamoto M; Komatsu H; Ueda R; Wada M; Furukawa TA
Cancer Sci; 2010 Dec; 101(12):2596-600. PubMed ID: 20946120
[TBL] [Abstract][Full Text] [Related]
16. Delayed nausea and vomiting continue to reduce patients' quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment.
Bloechl-Daum B; Deuson RR; Mavros P; Hansen M; Herrstedt J
J Clin Oncol; 2006 Sep; 24(27):4472-8. PubMed ID: 16983116
[TBL] [Abstract][Full Text] [Related]
17. Symptom experiences during chemotherapy treatment--with focus on nausea and vomiting.
Bergkvist K; Wengström Y
Eur J Oncol Nurs; 2006 Feb; 10(1):21-9. PubMed ID: 15908274
[TBL] [Abstract][Full Text] [Related]
18. The effectiveness of progressive muscle relaxation training in managing chemotherapy-induced nausea and vomiting in Chinese breast cancer patients: a randomised controlled trial.
Molassiotis A; Yung HP; Yam BM; Chan FY; Mok TS
Support Care Cancer; 2002 Apr; 10(3):237-46. PubMed ID: 11904789
[TBL] [Abstract][Full Text] [Related]
19. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
Sorbe BG
Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
[TBL] [Abstract][Full Text] [Related]
20. WISECARE+: Results of a European study of a nursing intervention for the management of chemotherapy-related symptoms.
Kearney N; Miller M; Maguire R; Dolan S; MacDonald R; McLeod J; Maher L; Sinclair L; Norrie J; Wengström Y
Eur J Oncol Nurs; 2008 Dec; 12(5):443-8. PubMed ID: 18842457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
